Andrea Howard

Andrea Howard

Andrea Howard

Associate Professor
Epidemiology (in ICAP) at the Columbia University Medical Center


722 West 168th St, Room 1316
New York NY USA 10032



Andrea A. Howard, MD, MS, is clinical and training unit director at ICAP where she oversees the clinical and laboratory aspects of ICAP's activities for prevention, care and treatment of HIV, tuberculosis and related conditions, as well as the design and implementation of training programs for a variety of learners. Dr. Howard is also involved in the design and implementation of integrated TB/HIV care and treatment programs at ICAP-supported sites in sub-Saharan Africa and provides HIV primary care at the Infectious Diseases Clinic at Harlem Hospital. Before joining the Columbia faculty, Dr. Howard was an assistant professor of Epidemiology & Population Health and Medicine at Albert Einstein College of Medicine and an attending physician at Montefiore Medical Center. She has extensive clinical experience in HIV, TB, and other infectious diseases in an inner-city setting. Dr. Howard's primary research interest is in TB/HIV. She is the principal investigator of two cluster-randomized trials aimed at defining best practices for integrating TB and HIV service delivery programs in sub-Saharan Africa. The NIH-funded ENhance Initiation and Retention in IPT Care for HIV Study (ENRICH Study), aims to evaluate the effectiveness of a combination intervention package versus standard of care to improve isoniazid preventive therapy initiation, adherence and completion among HIV-infected individuals in Ethiopia. The USAID-funded Start TB Patients on ART and Retain in Treatment (START) Study, aims to evaluate the effectiveness, cost-effectiveness and acceptability of a combination intervention package versus standard of care to improve early ART initiation and retention during TB treatment, as well as TB treatment success, among HIV-infected TB patients in Lesotho. Dr. Howard has also been an active investigator in a number of NIH- and CDC-funded cohort studies of women and drug users, including the HIV Epidemiologic Research (HER) Study, Women's Interagency HIV Study (WIHS), and the Bronx HERO cohort.



MS, 2000, Albert Einstein College of Medicine
MD, 1994, Weill Medical College of Cornell University
BA, 1990, Colgate Universtity


Areas of Expertise

HIV/AIDS, Infectious Disease, Tuberculosis, Addiction/Drug Abuse

Select Global Activities

, Ethiopia, Kenya, Mozambique, Nigeria, Rwanda, South Africa, Swaziland, Tanzania

Select Publications

Howard AA, Lo Y, Floris-Moore M, Klein RS, Fleischer N, Schoenbaum EE Hepatitis C virus infection is associated with insulin resistance among older adults with or at-risk for HIV infection AIDS 21 633-41 2007

Howard AA, Floris-Moore M, Lo Y, Arnsten JH, Fleischer N, Klein RS Abnormal glucose metabolism among older men with or at-risk for HIV infection HIV Med 7 389-96 2006

Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Fleischman N, Lo Y, Schoenbaum EE Disorders of glucose metabolism in HIV-infected women Clin Infect Dis 40 1492-9 2005

Howard AA, Arnsten JH, Gourevitch MN Effect of alcohol consumption on diabetes mellitus: a systematic review Ann Intern Med 140 211-19 2004

Howard AA, Klein RS, Schoenbaum EE Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users Clin Infect Dis 36 1318-23 2003

Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, Stone VE, Smith DK, Schoenbaum EE, for the HER Study Group A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women AIDS 16 2175-82 2002

Howard AA, Klein RS, Schoenbaum EE, Gourevitch MN Crack cocaine use and other risk factors for tuberculin positivity in drug users Clin Infect Dis 35 1183-90 2002

Back to Top